Literature DB >> 27304650

The RANKL/RANK/OPG signal trail: significance of genetic polymorphisms in the etiology of postmenopausal osteoporosis.

Hubert Wolski1, Krzysztof Drews, Anna Bogacz, Adam Kamiński, Magdalena Barlik, Joanna Bartkowiak-Wieczorek, Andrzej Klejewski, Marcin Ożarowski, Marian Majchrzycki, Agnieszka Seremak-Mrozikiewicz.   

Abstract

OBJECTIVES: Recent studies have demonstrated that disorders of bone metabolism, which is regulated by RANK/RANKL/OPG signaling pathway, are the cause of osteoporosis. The aim of the study was to investigate the distribution of genotypes of the RANK 575C>T and RANKL -643C>T polymorphisms and to analyze their relationship with bone parameters in postmenopausal women.
MATERIAL AND METHODS: A total of 310 postmenopausal Caucasian women (139 with osteoporosis, 107 with osteopenia, and 64 healthy postmenopausal controls) were included. Bone mineral density (BMD) at the lumbar region of the spine (L2-L4) was measured by dual energy X-ray absorptiometry (DXA). Genetic analysis was performed using the PCR-RFLP method.
RESULTS: Analysis of the frequency of genotypes and alleles of the RANK 575C>T and RANKL -643C>T polymorphisms did not show any statistically significant differences between the study groups (osteoporosis and osteopenia) and postmenopausal women with normal t-score value (ns). Notably, a significant association between the RANKL -643C>T polymorphism and body mass, such as BMI values in osteoporotic women (p<0.05), was observed.
CONCLUSIONS: Our results suggest lack of association between the 575C>T RANK polymorphism and the development of osteoporosis. The -643C>T RANKL polymorphism, through its significant influence on body weight and BMI value, may contribute to the development of osteoporosis in postmenopausal women.

Entities:  

Keywords:  RANKL/RANK/OPG signaling trail; genetic polymorphism; osteoporosis

Mesh:

Substances:

Year:  2016        PMID: 27304650     DOI: 10.5603/GP.2016.0014

Source DB:  PubMed          Journal:  Ginekol Pol        ISSN: 0017-0011            Impact factor:   1.232


  5 in total

Review 1.  Bioprinting and Organ-on-Chip Applications Towards Personalized Medicine for Bone Diseases.

Authors:  Chiara Arrigoni; Mara Gilardi; Simone Bersini; Christian Candrian; Matteo Moretti
Journal:  Stem Cell Rev Rep       Date:  2017-06       Impact factor: 5.739

Review 2.  Prevention and Treatment of Osteoporosis Using Chinese Medicinal Plants: Special Emphasis on Mechanisms of Immune Modulation.

Authors:  Hongyan Zhao; Ning Zhao; Peng Zheng; Xiaohong Xu; Meijie Liu; Dan Luo; Huihui Xu; Dahong Ju
Journal:  J Immunol Res       Date:  2018-02-20       Impact factor: 4.818

3.  Salidroside Improves Bone Histomorphology and Prevents Bone Loss in Ovariectomized Diabetic Rats by Upregulating the OPG/RANKL Ratio.

Authors:  Hongxing Zheng; Shanshan Qi; Chen Chen
Journal:  Molecules       Date:  2018-09-19       Impact factor: 4.411

4.  Analysis and Validation of Hub Genes in Blood Monocytes of Postmenopausal Osteoporosis Patients.

Authors:  Yi-Xuan Deng; Wen-Ge He; Hai-Jun Cai; Jin-Hai Jiang; Yuan-Yuan Yang; Yan-Rong Dan; Hong-Hong Luo; Yu Du; Liang Chen; Bai-Cheng He
Journal:  Front Endocrinol (Lausanne)       Date:  2022-01-13       Impact factor: 5.555

5.  Total flavonoids of Rhizoma Drynariae combined with calcium attenuate osteoporosis by reducing reactive oxygen species generation.

Authors:  Panyun Mu; Yimei Hu; Xu Ma; Jingru Shi; Zhendong Zhong; Lingyuan Huang
Journal:  Exp Ther Med       Date:  2021-04-14       Impact factor: 2.447

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.